Doctors told to exercise caution when prescribing anti-fungal drug Lamisil

[Guest guest]

Doctors told to exercise caution when prescribing anti-fungal drug

Lamisil

http://www.therapeuticsdaily.com/news/article.cfm?

contentValue=1383907 & contentType=sentryarticle & channelID=29

Irish Times - Jun. 05, 2007

The State's drug safety body has reminded doctors to exercise

caution when prescribing a drug commonly used to treat fungal

infections of the skin and nails.

In its latest drug safety newsletter, the Irish Medicines Board

(IMB) said it had received almost 100 reports of suspected adverse

reactions to terbenafine since it was first authorised for oral use

in the early 1990s. Terbenafine is marketed under the trade name

Lamisil.

Among the reactions recorded were inflammation of the liver which

the newsletter says may occur " with or without pre-existing liver

disease " .

Last month, the IMB suspended the licence of ...

To continue reading the complete article, login or register

below and get free instant access.

The complete article is 434 words long.